New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 5, 2012
10:38 EDTRHHBY, REGNCompounding linked to new round of contamination, NY Times says
A deadly meningitis outbreak is being linked to a steroid drug being contaminated by fungus at the New England Compounding Center, according to a New York Times report. The report noted that the center has a history of problems, including past FDA warnings cautioning it against opening sterile vials of Roche's (RHHBY) Avastin. The Fly notes that Regeneron Pharmaceuticals' (REGN) Eylea competes with Avastin as a treatment for Wet Macular Degeneration. Reference Link
News For RHHBY;REGN From The Last 14 Days
Check below for free stories on RHHBY;REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2013
19:01 EDTREGNOn The Fly: After Hours Movers
Subscribe for More Information
17:26 EDTRHHBY, REGNRegeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information
17:20 EDTRHHBY, REGNRegeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information
07:28 EDTREGNAmerican Thoracic Society to hold a conference
Subscribe for More Information
May 17, 2013
10:07 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:16 EDTREGNRegeneron initiated with a Neutral at UBS
Subscribe for More Information
06:33 EDTREGNAmerican Thoracic Society to hold a conference
Subscribe for More Information
May 15, 2013
15:59 EDTRHHBYRoche exploring sale of blood glucose meters unit, Reuters says
Subscribe for More Information
12:13 EDTRHHBYRoche management to meet with Jefferies
Meeting to be held in London on May 17 hosted by Jefferies.
11:38 EDTRHHBYRoche says FDA approves Tarceva tablets for specific lung cancer situation
Subscribe for More Information
05:39 EDTREGNSanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information
May 14, 2013
16:55 EDTRHHBYFDA approves Roche's cobas EGFR mutation test with Tarceva
Subscribe for More Information
07:34 EDTREGNRegeneron outlook positive, says RBC Capital
Subscribe for More Information
May 13, 2013
08:55 EDTRHHBYBiosimiliar drug bill to be taken up in Senate, LA Times reports
Subscribe for More Information
07:30 EDTRHHBYTechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16.
May 10, 2013
15:59 EDTRHHBYRoche spokesman reiterates that Illumina is "off the table," Bloomberg reports
Subscribe for More Information
11:48 EDTRHHBYDrugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information
07:24 EDTREGNCredit Suisse to host a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.